Gene Ontology |
GO ID | Evidence Type | GO Description |
GO:0000122 |
IEA |
negative regulation of transcription from RNA polymerase II promoter |
GO:0000978 |
IEA |
RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0001077 |
IEA |
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0001078 |
IEA |
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription |
GO:0001103 |
IEA |
RNA polymerase II repressing transcription factor binding |
GO:0001190 |
IDA |
RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription |
GO:0001666 |
IEA |
response to hypoxia |
GO:0003677 |
IDA |
DNA binding |
GO:0003700 |
IMP |
sequence-specific DNA binding transcription factor activity |
GO:0003707 |
TAS |
steroid hormone receptor activity |
GO:0004872 |
IDA |
receptor activity |
GO:0004879 |
IEA |
ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0005515 |
IPI |
protein binding |
GO:0005634 |
TAS |
nucleus |
GO:0005654 |
TAS |
nucleoplasm |
GO:0006006 |
TAS |
glucose metabolic process |
GO:0006351 |
IEA |
transcription, DNA-templated |
GO:0006355 |
TAS |
regulation of transcription, DNA-templated |
GO:0006629 |
TAS |
lipid metabolic process |
GO:0006631 |
TAS |
fatty acid metabolic process |
GO:0007507 |
IEA |
heart development |
GO:0008144 |
ISS |
drug binding |
GO:0008270 |
IEA |
zinc ion binding |
GO:0008289 |
IDA |
lipid binding |
GO:0008544 |
IMP |
epidermis development |
GO:0010468 |
IMP |
regulation of gene expression |
GO:0010871 |
IEA |
negative regulation of receptor biosynthetic process |
GO:0010887 |
IEA |
negative regulation of cholesterol storage |
GO:0010891 |
IEA |
negative regulation of sequestering of triglyceride |
GO:0019217 |
IMP |
regulation of fatty acid metabolic process |
GO:0019902 |
IEA |
phosphatase binding |
GO:0019904 |
IEA |
protein domain specific binding |
GO:0030522 |
IEA |
intracellular receptor signaling pathway |
GO:0031624 |
IEA |
ubiquitin conjugating enzyme binding |
GO:0032091 |
IEA |
negative regulation of protein binding |
GO:0032099 |
IMP |
negative regulation of appetite |
GO:0032403 |
IEA |
protein complex binding |
GO:0032868 |
IEA |
response to insulin |
GO:0032922 |
IDA |
circadian regulation of gene expression |
GO:0035095 |
IEA |
behavioral response to nicotine |
GO:0042060 |
IMP |
wound healing |
GO:0042157 |
IEA |
lipoprotein metabolic process |
GO:0042752 |
IDA |
regulation of circadian rhythm |
GO:0043401 |
IEA |
steroid hormone mediated signaling pathway |
GO:0043565 |
IDA |
sequence-specific DNA binding |
GO:0045722 |
IMP |
positive regulation of gluconeogenesis |
GO:0045776 |
IEA |
negative regulation of blood pressure |
GO:0045893 |
IMP |
positive regulation of transcription, DNA-templated |
GO:0045944 |
IDA |
positive regulation of transcription from RNA polymerase II promoter |
GO:0046321 |
IMP |
positive regulation of fatty acid oxidation |
GO:0046982 |
TAS |
protein heterodimerization activity |
GO:0051525 |
IEA |
NFAT protein binding |
GO:0070166 |
IMP |
enamel mineralization |
GO:0072363 |
IEA |
regulation of glycolytic by positive regulation of transcription from RNA polymerase II promoter |
GO:0072366 |
IEA |
regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter |
GO:0072369 |
IEA |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter |
GO:0097371 |
IEA |
MDM2/MDM4 family protein binding |
GO:1901215 |
IEA |
negative regulation of neuron death |
GO:2000678 |
IEA |
negative regulation of transcription regulatory region DNA binding |